Crispr Therapeutics Ag (CRSP)

Change in Working Capital

$14.44M

TTM · Period ending: · USD

CRSP logo

CRSP Change in Working Capital

Latest reported$14.44M
CRSP TTM Change in Working Capital ($79.09M → $14.44M)
High-resolution chart · PNG

CRSP change in working capital history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Crispr Therapeutics Ag Change in Working Capital — Trailing twelve months (TTM) (USD)
Period endingChange in Working Capital (USD)
14,439,000
1,625,000
71,882,000
24,891,000
-26,374,000
628,000
156,270,000
-23,350,000
69,568,000
-20,002,000
-193,585,000
-21,234,000
-36,608,000
50,657,000
19,845,000
69,960,000
42,070,000
47,325,000
26,859,000
11,820,000
-404,000
18,645,000
33,440,000
5,532,000
-12,601,000
-41,169,000
-48,430,000
-20,219,000
6,529,000
5,600,000
10,550,000
-16,427,000
-19,295,000
-20,874,000
-25,391,000
-191,000
-3,102,000
-5,316,000
1,781,000
79,681,000
79,967,000
80,195,000
79,089,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.